cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Paratek Pharmaceuticals Inc
10 own
33 watching
Current Price
$0
$0.21
(10.71%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
112.27M
52-Week High
52-Week High
3.65
52-Week Low
52-Week Low
1.29
Average Volume
Average Volume
10.46M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization112.27M
icon52-Week High3.65
icon52-Week Low1.29
iconAverage Volume10.46M
iconDividend Yield--
iconP/E Ratio--
What does the Paratek Pharmaceuticals Inc do?
Paratek Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics based upon tetracycline chemistry in the United States. Its lead product candidates include omadacycline, a broad-spectrum, intravenous, and oral antibiotic, which is in Phase III clinical stage for use as a monotherapy antibiotic for acute bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), urinary tract infections, and other community-acquired bacterial infections; and Sarecycline, a tetracycline-derived compound that is in Phase III clinical trial for the treatment of acne and rosacea. The company has special protocol assessment agreements with Food and Drug Administration for the Phase III studies for ABSSSI and CABP. It has collaborative research and license agreement with Allergan plc to research, develop, and commercialize tetracycline products; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and license agreement with Shin Nippon Biomedical Laboratories Ltd. to develop TO-2070 for the treatment of acute migraine. The company also has a cooperative research and development agreement with the U.S. Army Medical Research Institute of Infectious Diseases to study omadacycline against pathogenic agents causing infectious diseases. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.
Read More
How much money does Paratek Pharmaceuticals Inc make?
News & Events about Paratek Pharmaceuticals Inc.
Globe Newswire
1month ago
BOSTON, May 01, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Tuesday, May 9 at 4:30 p.m. EDT to report financial results for first quarter 2023.The audio webcast can be accessed under "...
Globe Newswire
1month ago
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government...
Globe Newswire
2 months ago
-- NUZYRA (omadacycline) Generated Net U.S. Sales of $98.7 Million from the Core Commercial Business, a 45% Increase Over the Prior Year -- Continued Progress on the Rare Disease Nontuberculous Mycobacteria (NTM) & BARDA Project BioShield Anthrax Programs BOSTON, March 16, 2023 (GLOBE NEWSWIRE) -- ...
Globe Newswire
3 months ago
BOSTON, March 08, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a conference call and live audio webcast on Thursday, March 16, 2023 at 8:30 a.m. EST to provide a corporate update and report its financial results for fourth quarter ...
Frequently Asked Questions
Frequently Asked Questions
What is Paratek Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Paratek Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Paratek Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Paratek Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Paratek Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Paratek Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Paratek Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Paratek Pharmaceuticals Inc?
plus_minus_icon
What percentage is Paratek Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Paratek Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.21
(10.71%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00